Effect of Low-Carbohydrate Versus Balanced Diets on Anthropometric Blood Pressure, ApoB, and hsCRP in Healthy Adults
Comparative Evaluation of Low-Carbohydrate and Balanced Diets on Anthropometric and Cardiovascular Risk Markers in Healthy Volunteers: A Single-Blind Randomized Controlled Trial
1 other identifier
interventional
135
1 country
3
Brief Summary
The goal of this clinical trial is to explore the effect of a low-carbohydrate diet and a balanced diet. The main questions it aims to answer are:
- Does a 4-week diet intervention improve anthropometric and cardiovascular parameters?
- What diet is more effective in promoting weight loss and improving cardiovascular parameters? Researchers will compare a low-carbohydrate diet and a balanced diet with control group. Participants will:
- Take the intervention diet or control diet for 4 weeks
- will submit food records three times a week
- Visit the study location 2 times for check up and test
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2026
Shorter than P25 for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 20, 2026
CompletedStudy Start
First participant enrolled
February 25, 2026
CompletedFirst Posted
Study publicly available on registry
March 9, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 29, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 29, 2026
March 9, 2026
March 1, 2026
3 months
February 20, 2026
March 4, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change from baseline in Body Mass Index (BMI) after 4 weeks
Body mass index (BMI) will be calculated as weight in kilograms divided by the square of height in meters (kg/m²). Body weight will be measured using a Seca 876 scale (Hamburg, Germany) with an accuracy of 0.1 kg, and height will be measured using a Seca 213 stadiometer (Hamburg, Germany) with an accuracy of 0.1 cm. Measurements will be performed at baseline and at the end of the intervention.
baseline and 4 weeks
Secondary Outcomes (4)
Change from baseline in the mean seated through cuff Systolic pressure at 4 weeks
Baseline and 4 weeks
Change from baseline in the mean seated Diastolic pressure at 4 weeks
Baseline & 4 weeks
Change from baseline in Serum Apolipoprotein B (ApoB) concentration at 4 weeks
Baseline and week 4.
Change from baseline in serum High-Sensitivity C-Reactive Protein (hsCRP) concentration at 4 weeks
Baseline and 4 weeks
Study Arms (3)
Low carbohydrate diet
EXPERIMENTALThe low-carbohydrate diet group will receive a dietary intervention focused on a diet with \<45% of total energy from carbohydrates. Participants will receiving three meals and two snacks for 20 days (on weekdays for four weeks). During the study period, participants will submit food records three times a week (two days on weekdays and one day on weekends).
Balance diet
EXPERIMENTALBalanced diet group will receive a dietary intervention consisting of 45-65% of total calories from carbohydrates, 20-25% from fat, and 10% from protein. Participants will receiving three meals and two snacks for 20 days (on weekdays for four weeks). During the study period, participants will submit food records three times a week (two days on weekdays and one day on weekends).
Control group
NO INTERVENTIONControl group (without dietary intervention), will maintain their usual diet. During the study period, participants will submit food records three times a week (two days on weekdays and one day on weekends).
Interventions
Eligibility Criteria
You may qualify if:
- age 18-59 years old
- ability to follow the prescribed meal plan and examination schedule during the study
- willing to participate in this study by signing informed consent
You may not qualify if:
- a history of type 1 or type 2 diabetes,
- autoimmune disease
- thyroid disease
- major surgery in the past six months,
- ,- eating disorders,
- food allergy
- participation in other clinical trials
- impaired kidney function with serum creatinine ≥1.5 mg/dL
- abnormal liver function with alanine aminotransferase and aspartate aminotransferase levels exceeding threefold.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Faculty of medicine Universitas Trisakti
Jakarta, DKI Jakarta, 11440, Indonesia
Faculty of medicine Universitas Trisakti
Jakarta, DKI Jakarta, 11440, Indonesia
Triisakti University
Jakarta, DKI Jakarta, 11440, Indonesia
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
February 20, 2026
First Posted
March 9, 2026
Study Start
February 25, 2026
Primary Completion (Estimated)
May 29, 2026
Study Completion (Estimated)
May 29, 2026
Last Updated
March 9, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
- Time Frame
- 6 month after publish
- Access Criteria
- principle investigator that need access the data can contact contact me through
Data will be provided upon request